ICARS provides a unique value proposition – a funded partnership, collaborating with low- and middle-income countries to co-develop evidence-based, context specific, cost-effective and sustainable solutions to mitigate AMR, advancing each country’s individual National Action Plan.

At ICARS, our mission is to partner with Low- and Middle-income countries (LMICs) in their efforts to reduce drug-resistant infections. We do this by co-developing tailored solutions with LMIC governments and researchers, who then implement them on the ground using ICARS funding and expertise, building on AMR National Action Plans.

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide.

Since 1963, we’ve been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place.

The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Resolve to Save Lives was created in 2017 by Dr. Tom Frieden, former director of the US Centers for Disease Control and Prevention (CDC). Through his work in government and with philanthropy, Dr. Frieden pinpointed a unique problem: no one is thinking about how to systematically combat the world’s leading killers. Heart disease carries the distinction of being the world’s #1 cause of death. And few organizations raise their focus from one disease to look at epidemics as a whole—and how they can be prevented. Resolve to Save Lives is committed to saving lives from these preventable causes by partnering with government and civil society to implement scalable, proven strategies.

We prioritize partnerships with national and local organizations in low- and middle-income countries to co-create, advocate for, and scale up activities in heart disease prevention and epidemic preparedness. We work with global organizations to produce and promote policies that maximize health gains. Our funders include Bloomberg Philanthropies, the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, which is funded with support from the Chan Zuckerberg Foundation. We are resolved to save lives.

Essity is a leading global hygiene and health company, dedicated to improving well-being through excellent products and services. As part of its Personal Care offering, Essity provides innovative, high-quality medical solutions in Compression, Wound Care and Orthopedics. With renowned brands such as Leukoplast, Cutimed, JOBST, Actimove and Delta-Cast.

Since the acquisition of BSN Medical in 2017, Essity has extended its leading market positions in a number of medical solution categories in around 140 countries, underlining a commitment to improve the quality of life of people everywhere.

With a comprehensive portfolio of products, solutions and services, Essity is one of the four big global players in its categories. The focus is on serving the needs of customers, which include retail trade, online sales, pharmacies, hospitals, distributors, care institutions and consumers.

Under the brand Leukoplast, Essity’s offering for Acute Wound Care ranges from surgical tapes and retention bandages to surgical dressings as well as adhesive bandages and plasters.

Developed specifically to relieve patients from the burden of chronic and complex wounds, Cutimed empowers healthcare professionals with innovative solutions to manage all aspects of wound healing.

JOBST is the global Number ONE in Compression Therapy, offering a wide selection of products in the field of phlebology, lymphology and lipedema, such as medical compression garments, bandages and wraps.

As the global market leader in both Fracture Management and Physiotherapy, Essity draws on over 80 years of experience in non-invasive Orthopedics. Delta-Cast offers a complete, high-quality range for casting and splinting. This is complemented by Actimove with its medically engineered braces and supports portfolio. The Physiotherapy portfolio includes tapes and bandages.

WaterAid is an international not-for-profit organization, working in 22 countries to make clean water, decent toilets and good hygiene normal for everyone within a generation.

WaterAid works at multiple levels with governments, communities, service providers, research institutes and many more to deliver inclusive water, sanitation and hygiene (WASH) services, promote hygiene behaviour change, and demonstrate how WASH can be sustained and expanded. They link policymakers with communities and local partners, and promote women’s participation and leadership in WASH decision-making. They use evidence and lessons learned to influence governments, donors and financial institutions to invest in WASH services and rally support from around the world.

One of WaterAid’s Strategic Aims in the current global strategy (2022-2032) is focused on prioritizing WASH across the health sector to improve public health. Universal, sustainable and safe WASH are essential foundations of human health. WaterAid is working with governments and partners to strengthen health systems through integrating WASH and hygiene behaviours change and prioritise the requirements of women and girls, who make up the majority of health service users and health workers

 

TBC

As more diseases are discovered worldwide, Seegene is leading the development of new technology for accurate diagnosis. We are committed to advancing healthcare through innovative PCR technologies and high- quality products. Our mission is to enhance diagnostic accuracy and efficiency for laboratories worldwide. Join us in shaping the future of molecular diagnostics!

Your total surgical, decontamination and sterile processing solutions partners for more than 50 years.

TBC